Related Experiment Videos
Potential markers predicting distant metastasis in axillary node-negative breast carcinoma
1Breast Cancer Pathological Department and Research Laboratory, Tianjin Tumor Hospital, Tianjin Medical University, Tianjin, China. yunniu@public.tpt.tj.cn
International Journal of Cancer
|March 29, 2002
Summary
Predicting distant metastasis in axillary node-negative breast cancer is challenging. Researchers identified nm23, Cathepsin-D, and EGFR as key biomarkers to identify high-risk patients for personalized treatment.
Area of Science:
- Oncology
- Biomarker Discovery
- Breast Cancer Research
Background:
- Prognostic markers for axillary node-negative (ANN) breast cancer are limited.
- Accurate prediction of distant metastasis risk is crucial for patient management.
Purpose of the Study:
- To identify novel biomarkers for predicting distant metastasis in ANN breast carcinoma.
- To detect patients with a high risk of metastasis for tailored therapy.
Main Methods:
- A case-control study involving 192 patients (64 metastatic ANN, 64 recurrence-free ANN, 64 node-positive ANP).
- Immunohistochemistry and in situ hybridization to analyze nm23, Cathepsin-D (Cath-D), Epidermal Growth Factor Receptor (EGFR), and Laminin Receptor (LR).
Main Results:
- Lower nm23 expression correlated with poor prognosis in ANN patients.
- Higher Cath-D, EGFR, and LR protein levels were observed in poor prognosis ANN and ANP groups.
- Multiple regression analysis confirmed nm23, Cath-D, and EGFR as predictors of distant metastasis.
Conclusions:
- Combined detection of nm23, Cath-D, and EGFR shows promise as predictive markers for distant metastasis in ANN breast cancer.
- Quantitative analysis of these markers, alongside clinicopathologic factors, can aid in risk stratification and personalized treatment selection.